当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 现金流量表

易瑞生物

(300942)

  

流通市值:43.87亿  总市值:43.87亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金117,461,879.8560,678,544.67227,748,709.79151,888,509.56
  收到的税费返还14,381.9012,934,578.6312,943,692.74
  收到其他与经营活动有关的现金11,537,678.956,588,593.5217,597,868.6718,824,157.14
  经营活动现金流入小计129,013,940.767,267,138.19258,281,157.09183,656,359.44
  购买商品、接受劳务支付的现金47,579,131.6327,327,577.3197,172,677.3646,893,595.1
  支付给职工以及为职工支付的现金48,033,025.3327,403,778.2283,379,778.4762,874,077.37
  支付的各项税费1,680,684.621,248,847.73,340,489.362,269,007.01
  支付其他与经营活动有关的现金31,741,451.5812,702,169.4340,130,009.355,588,202.08
  经营活动现金流出小计129,034,293.1668,682,372.66224,022,954.49167,624,881.56
  经营活动产生的现金流量净额-20,352.46-1,415,234.4734,258,202.616,031,477.88
二、投资活动产生的现金流量:
  收回投资收到的现金--37,661,616.1634,161,616.16
  取得投资收益收到的现金3,707,966.251,762,483.793,463,334.431,449,290.73
  处置固定资产、无形资产和其他长期资产收回的现金净额1,004,606.63669,9001,230,360275,622.4
  处置子公司及其他营业单位收到的现金净额359,143.42359,143.42354,239.56275,634.79
  收到的其他与投资活动有关的现金377,213,774.35216,213,774.35718,795,004.49512,609,095.92
  投资活动现金流入小计382,285,490.65219,005,301.56761,504,554.64548,771,260
  购建固定资产、无形资产和其他长期资产支付的现金20,543,108.9116,141,862.48174,103,679.98107,330,014.64
  投资支付的现金7,150,0001,800,000--
  支付其他与投资活动有关的现金229,571,355.7640,343,042.76934,918,090.47757,058,262.53
  投资活动现金流出小计257,264,464.6758,284,905.241,109,021,770.45864,388,277.17
  投资活动产生的现金流量净额125,021,025.98160,720,396.32-347,517,215.81-315,617,017.17
三、筹资活动产生的现金流量:
  吸收投资收到的现金240,000240,0002,000,0002,000,000
  其中:子公司吸收少数股东投资收到的现金240,000240,0002,000,0002,000,000
  取得借款收到的现金5,688,827.625,688,827.62108,818,522.150,000,000
  收到其他与筹资活动有关的现金--1,595,835.93-
  筹资活动现金流入小计5,928,827.625,928,827.62112,414,358.0352,000,000
  偿还债务支付的现金36,094,463.423,727,231.7110,216,336.846,298,263.42
  分配股利、利润或偿付利息支付的现金10,035,189.931,545,455.145,337,261.424,306,357.43
  其中:子公司支付给少数股东的股利、利润-0--
  支付其他与筹资活动有关的现金-09,721,964.079,721,956.63
  筹资活动现金流出小计46,129,653.355,272,686.8525,275,562.3320,326,577.48
  筹资活动产生的现金流量净额-40,200,825.73656,140.7787,138,795.731,673,422.52
四、汇率变动对现金及现金等价物的影响4,472,755.281,792,812.671,503,302.13-932,712.5
五、现金及现金等价物净增加额89,272,603.07161,754,115.29-224,616,915.38-268,844,829.27
  加:期初现金及现金等价物余额257,131,959.42257,131,959.42481,748,874.8481,599,628.67
  期末现金及现金等价物余额346,404,562.49418,886,074.71257,131,959.42212,754,799.4
补充资料:
  净利润1,889,832.3-16,619,408.29-
  资产减值准备781,587.6-10,184,622.46-
  固定资产和投资性房地产折旧10,822,484.9-11,658,015.8-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,822,484.9-11,658,015.8-
  无形资产摊销970,565.76-1,933,445.41-
  长期待摊费用摊销493,641.32-1,739,322.67-
  处置固定资产、无形资产和其他长期资产的损失-171,594.88--2,283,492.87-
  固定资产报废损失-52,820.68-1,109,521.34-
  公允价值变动损失-1,704,458.31--1,871,304.38-
  财务费用8,351,020.95-18,666,370.68-
  投资损失2,323,090.92-5,849,539.02-
  递延所得税-1,245,548.37-2,977,120.92-
  其中:递延所得税资产减少-1,245,548.37-2,977,120.92-
  存货的减少-12,281,469.91-20,298,109.65-
  经营性应收项目的减少3,370,358.86--20,850,509.75-
  经营性应付项目的增加-11,875,686.92--58,743,753.18-
  其他-1,691,356-19,264,541.97-
  现金的期末余额346,404,562.49-257,131,959.42-
  减:现金的期初余额257,131,959.42-481,748,874.8-
  现金及现金等价物的净增加额89,272,603.07--224,616,915.38-
公告日期2025-08-282025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑